Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barbour

Showing results (291-300 of 296) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 296 results.
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2020
Identifying Outcomes Important to Patients with Glomerular Disease and Their CaregiversSimon A Carter, Talia Gutman, Charlotte Logeman, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Kidney International Reports|January 10, 2022
A Focus Group Study of Self-Management in Patients With Glomerular DiseaseSimon A Carter, Claris Teng, Talia Gutman, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
Pageof 30

Showing results (291-300 of 296) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 296 results.
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2020
Identifying Outcomes Important to Patients with Glomerular Disease and Their CaregiversSimon A Carter, Talia Gutman, Charlotte Logeman, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Kidney International Reports|January 10, 2022
A Focus Group Study of Self-Management in Patients With Glomerular DiseaseSimon A Carter, Claris Teng, Talia Gutman, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
Pageof 30